Theriva Biologics, Inc.
TOVX · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $12 | $23 | $42 | $67 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $3 | $2 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $2 | $4 | $2 |
| Total Curr. Assets | $16 | $27 | $46 | $69 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $1 |
| Goodwill | $0 | $6 | $6 | $0 |
| Intangibles | $17 | $20 | $19 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $3 | $0 |
| Other NC Assets | $0 | $0 | -$3 | $0 |
| Total NC Assets | $19 | $28 | $26 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $35 | $55 | $72 | $70 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $1 |
| Short-Term Debt | $1 | $1 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $6 | $5 | $6 | $3 |
| Total Curr. Liab. | $8 | $7 | $7 | $4 |
| LT Debt | $1 | $2 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $1 | $0 | $2 | $0 |
| Other NC Liab. | $7 | $7 | $7 | $0 |
| Total NC Liab. | $9 | $9 | $10 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $2 | $1 | $2 |
| Total Liabilities | $16 | $16 | $17 | $5 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $3 | $3 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$335 | -$309 | -$291 | -$271 |
| AOCI | -$1 | $0 | -$1 | $0 |
| Other Equity | $355 | $346 | $343 | $337 |
| Total Equity | $19 | $40 | $55 | $65 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $35 | $55 | $72 | $70 |
| Net Debt | -$10 | -$21 | -$40 | -$66 |